BRIEF-Cyclacel Pharmaceuticals Says Datuk Dr.Doris Wong Sing Ee Elected As CEO & Executive Director
ReutersFeb 27, 2025 8:24 PM
Feb 27 (Reuters) - Cyclacel Pharmaceuticals Inc CYCC.O:
CYCLACEL PHARMACEUTICALS ANNOUNCES CLOSING OF A CHANGE OF CONTROL TRANSACTION AND APPOINTMENT OF NEW EXECUTIVE LEADERSHIP
CYCLACEL PHARMACEUTICALS INC - DAVID LAZAR RESIGNS AS INTERIM CEO AND SECRETARY
CYCLACEL PHARMACEUTICALS INC - DATUK DR. DORIS WONG SING EE ELECTED AS CEO AND EXECUTIVE DIRECTOR
CYCLACEL PHARMACEUTICALS INC - KIU CU SENG APPOINTED AS EXECUTIVE DIRECTOR, SECRETARY AND CFO
Source text: ID:nGNX2q1q8
Further company coverage: CYCC.O
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
Apple’s Big September Moment Is Almost Here — What’s Priced In?
TradingKey - Apple (AAPL) has staged a strong rebound lately, with shares up 14% in August as investors breathed a sigh of relief over easing tariff risks. But whether the rally can keep going may depend on one thing: next week’s product launch.TradingKey
4 hours ago
U.S. August Nonfarm Payroll Preview: Risks Focus on Downward Revision of July Data
TradingKey - On 5 September 2025, the U.S. Department of Labour will release the August Non-Farm Payrolls report. The market widely expects August to see an addition of 75,000 non-farm jobs, roughly in line with July’s 73,000.TradingKey
Thu, Sep 4
Unlocking Gold’s Next Leg: $4,000 in Reach by 2025？
TradingKey - Gold has kicked off a fresh uptrend in early September, breaking out of months of compression and reclaiming key territory. The decisive move above $3,500 establishes a new support base and puts higher objectives back on the table for the weeks aheadTradingKey
Thu, Sep 4
US NFP Nightmares Preview: A Tiny August Revision, a Huge Annual Benchmark Cut And a Fed in Flux
TradingKey - Wall Street expects modest job growth and a rebound in the unemployment rate in August NFP report, a balanced outcome that could support a September rate cut. However, a massive downward revision — a “terrifying scene” — and anomalies on the supply side could plunge the Fed into deeperTradingKey
Wed, Sep 3
 (1).jpg)
Tradingkey
